Rate My Professor Lawrence Richer

Lawrence Richer, MD, MSc (Clinical Epidemiology), is a Professor in the Department of Pediatrics, Division of Neurology, at the University of Alberta and a practicing pediatric neurologist. He serves as Associate Dean, Research, for the College of Health Sciences, where he advances support for impactful interdisciplinary health research, clinical trials, and the use of health data to improve patient outcomes. Richer is also the Center Director of the Northern Alberta Clinical Trials and Research Center (NACTRC) and Chair and Academic Lead of the Precision Health Signature Area (PHSA), leading efforts in drug discovery, genomics, cell therapies, and artificial intelligence applied to health. Previously, he held the role of Vice-Dean of Research (Clinical) for the Faculty of Medicine and Dentistry. His career at the University of Alberta includes a professorship since 2001.

Richer's research focuses on pediatric migraine and headache disorders, as well as pediatric autonomic disorders, including Postural Orthostatic Tachycardia Syndrome (POTS), with investigations into the mechanisms and management of orthostatic intolerance, fatigue, concussion, long COVID, and chronic migraine. He has authored key publications such as the 'Canadian Cardiovascular Society Position Statement on Orthostatic Intolerance' (2020), 'Treatment of Children With Migraine in Emergency Departments' (2010), 'Drugs for the Acute Treatment of Migraine in Children and Adolescents' (Cochrane Review, 2016), 'Emergency Department Management of Acute Migraine in Children and Adolescents' (2007), and recent studies including 'The Healthcare Cost of Migraine: A Retrospective Cohort Study from Alberta, Canada' (2025) and 'Healthcare Cost of Multiple Sclerosis and in Relation to Disability Level in Alberta' (2024). Through his leadership in clinical trials and precision health, Richer influences advancements in pediatric neurology and broader health research platforms at the University of Alberta.